Device therapies in the post-myocardial infarction patient with left ventricular dysfunction

The American Journal of Cardiology
Alan H KadishJohn P DiMarco

Abstract

The post-myocardial infarction (MI) patient with left ventricular dysfunction (LVD) is at risk for ventricular arrhythmias resulting in sudden cardiac death. In high-risk post-MI patients with a depressed left ventricular ejection fraction, prophylactic implantable cardioverter defibrillators (ICDs) may significantly improve survival. These benefits are in addition to those of optimal pharmacologic therapy, and ICD therapy should be considered the standard of care in these patients. Recent device trials have demonstrated the benefits of prophylactic ICD placement in patients who have been selected based on post-MI left ventricular systolic dysfunction alone. In addition, cardiac resynchronization therapy can improve the quality of life beyond that achievable with drug therapy alone and should be considered in patients with symptomatic heart failure with QRS prolongation. Further risk stratification studies of post-MI LVD patients will allow ICD therapy to be applied in a more cost-effective manner.

References

Mar 15, 1997·The American Journal of Cardiology·J J GoldbergerA H Kadish
Dec 31, 1997·The New England Journal of Medicine·UNKNOWN Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators
Dec 18, 1998·The American Journal of Cardiology·G A LanzaA Maseri
Feb 17, 1999·Pacing and Clinical Electrophysiology : PACE·P J BestM S Stanton
Dec 12, 2001·Journal of the American College of Cardiology·J J BaileyM Hodges
Mar 22, 2002·The New England Journal of Medicine·Arthur J MossUNKNOWN Multicenter Automatic Defibrillator Implantation Trial II Investigators
Sep 6, 2002·Journal of Cardiovascular Electrophysiology·Eric J RashbaMichael R Gold
Nov 13, 2002·Journal of the American College of Cardiology·Maria Vittoria PitzalisPaolo Rizzon
Dec 24, 2002·Current Opinion in Cardiology·Michael R Gold, William Spencer
Aug 13, 2003·Circulation·Thomas J WangRamachandran S Vasan
Oct 1, 2003·Pacing and Clinical Electrophysiology : PACE·Bruce S StamblerUNKNOWN Pacemaker Selection in the Elderly Trial Investigators
Nov 11, 2003·European Journal of Heart Failure·Amala A LouisJohn G F Cleland
Nov 26, 2003·Circulation·William T Abraham, David L Hayes
May 21, 2004·The New England Journal of Medicine·Michael R BristowUNKNOWN Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators
May 21, 2004·The New England Journal of Medicine·Alan KadishUNKNOWN Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators
Jun 9, 2004·Circulation·Mark Josephson, Hein J J Wellens
Aug 18, 2004·Journal of the American College of Cardiology·Andrew VoigtSamir Saba
Dec 14, 2004·The New England Journal of Medicine·Stefan H HohnloserUNKNOWN DINAMIT Investigators
Dec 20, 2005·Journal of the American College of Cardiology·Amir Kashani, S Serge Barold
Jan 13, 2006·Circulation·Thomas ThomUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Jan 18, 2006·Journal of the American College of Cardiology·Daniel M BloomfieldJohn M Fontaine
Jan 31, 2006·Pacing and Clinical Electrophysiology : PACE·Charles D Swerdlow, Paul A Friedman
Feb 16, 2006·JAMA : the Journal of the American Medical Association·Zachary Goldberger, Rachel Lampert
Feb 28, 2006·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Eric J RashbaAlan Kadish
Aug 22, 2006·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Eric C SteckerSumeet S Chugh

❮ Previous
Next ❯

Citations

Nov 29, 2011·The International Journal of Cardiovascular Imaging·Denisa MuraruSabino Iliceto
Oct 3, 2008·The American Journal of Cardiology·Matthew E HarinsteinMihai Gheorghiade
Oct 3, 2008·The American Journal of Cardiology·James D FlahertyCharles J Davidson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Cardiogenic Shock

Cardiogenic shock is a devastating consequence of acute myocardial infarction and is associated with an extremely high mortality. Here is the latest research.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.